View Article

  • Barriers And Facilitators to HPV Immunisation Uptake Among Adolescents: A Systematic Review

  • 1Principal (child health nursing),mims nursing institutes, VZM, Andhra Pradesh

    2 Professor cum HOD (Obstetrics & Gynaecological Nursing)Postgraduate College of Nursing, CHRI, Gwalior (M.P)

    3 assistant professor (community health nursing),CON, GMC, Azamgarh

    4Associate Professor 9community health nursing),GITAM Institute of Nursing, GITAM Deemed to be University, GIMSR, Hospital campus, Rushikonda, Visakhapatnam

    5Nursing Tutor (Community Health Nursing),CON, GMC, Azamgarh

    6Associate Professor (Medical and Surgical Nursing),Syadwad Institute of Higher Education and Research, Baghpat.

Abstract

Background: Human papillomavirus (HPV) infection poses a significant public health challenge, linked to cervical cancer and other related diseases. Although effective and safe vaccines are available, adolescents' HPV vaccination rates are still low in many countries. Various social, cultural, economic, and healthcare factors affect vaccine acceptance and completion. Objective: This review aims to systematically analyse the existing literature on the barriers and enablers of HPV vaccination among adolescents. Methods: A systematic search was performed across databases like PubMed, Scopus, Google Scholar, and CINAHL, focusing on studies published in English from 2015 to 2025. The search used keywords such as “HPV vaccination,” “HPV immunisation,” “adolescents,” “barriers,” “facilitators,” and “vaccine uptake. " Included studies comprised quantitative, qualitative, and mixed methods research on adolescents aged 9–19 years. Data extraction and quality assessment followed PRISMA guidelines. Results: The review identified key barriers- including lack of awareness, fear of side effects, cultural and religious beliefs, misinformation, financial hurdles, limited healthcare access, parental hesitancy, and weak healthcare provider recommendations. Facilitators that improved uptake involved strong endorsements from healthcare providers, school- based vaccines, parental education, government efforts, social support, better vaccine access, and awareness initiatives. Educational programs and community engagement were particularly effective in increasing acceptance among adolescents and parents. Conclusion: Numerous interconnected factors influence HPV vaccine uptake among adolescents. Overcoming barriers through targeted education, culturally aware communication, supportive policies, and accessible vaccination services can boost coverage. Strengthening healthcare provider involvement and school vaccination programs has the potential to further increase HPV vaccination rates, ultimately helping prevent cervical cancer and other HPV- related diseases.

Keywords

HPV vaccination, adolescents, immunisation uptake, barriers, facilitators, cervical cancer prevention, systematic review

Introduction

× Popup Image

Human Papillomavirus (HPV) is a major public health concern associated with cervical cancer and other HPV-related diseases. Despite the availability of effective vaccines, HPV immunisation coverage among adolescents remains suboptimal in many countries. Various social, cultural, educational, economic, and healthcare-related factors influence vaccine uptake. Understanding these barriers and facilitators is essential for developing effective interventions and improving vaccination coverage. Human Papillomavirus (HPV) immunisation is highly effective at preventing HPV-related cancers, yet uptake among adolescents globally remains suboptimal. The introduction to this topic establishes the public health imperative, the multi-level barriers, and the successful intervention strategies that drive vaccination rates.  The Public Health Imperative: HPV is a highly prevalent sexually transmitted infection responsible for nearly all cervical cancers, as well as oropharyngeal, anal, and vulvar cancers. The vaccine yields maximum efficacy when administered during early adolescence (typically ages 9–14) prior to exposure to the virus. Despite global recommendations, coverage rates continue to fall short of targets, making research into the factors influencing uptake essential. Multi-Level Barriers to Uptake: Uptake among adolescents is frequently hindered by complex, interacting factors spanning the socio-ecological spectrum: Individual & Interpersonal: A widespread lack of awareness regarding HPV transmission and the benefits of the vaccine. Stigma surrounding sexually transmitted infections (STIs), coupled with parental safety and efficacy concerns, acts as a major deterrent. Systemic & Financial: High vaccine costs in low- and middle-income countries or out-of-pocket expenses, limited access to healthcare, and the absence of strong, proactive healthcare provider recommendations

AIM: To systematically review the barriers and facilitators influencing HPV immunisation uptake among adolescents.

OBJECTIVES

  1. To identify barriers affecting HPV vaccine uptake among adolescents.
  2. To identify facilitators promoting HPV immunisation among adolescents.
  3. To assess the influence of parental knowledge and attitudes on HPV vaccination.
  4. To evaluate the healthcare system and school-based factors affecting HPV vaccine acceptance.
  5. To provide recommendations for improving HPV immunisation coverage.

 

 

 

 

 

 

PRISMA

 

Records identified through databases
(n = 650)
?
Additional records identified
through other sources (n = 20)
?
?
Total records identified
(n = 670)
?
Duplicates removed
(n = 120)
?
Records screened
(n = 550)
?
Records excluded
(n = 420)
?
Full-text articles assessed
for eligibility (n = 130)
?
Full-text articles excluded
(n = 95)
?
Studies included in
qualitative synthesis
(n = 35)
?
Studies included in
quantitative synthesis
(n = 20)

 

Flow chart

 

PICO FRAMEWORK

 

Component

Description

Population (P)

Adolescents

Intervention (I)

HPV immunisation/vaccination programmes

Comparison (C)

Adolescents without intervention or low uptake settings

Outcome (O)

Barriers, facilitators, vaccine uptake, acceptance

 

COMMON BARRIERS

  • Lack of awareness about the HPV vaccine
  • Fear of side effects
  • Cultural and religious beliefs
  • Vaccine hesitancy
  • Limited access to healthcare services
  • Financial constraints
  • Lack of parental consent
  • Inadequate recommendations from healthcare professionals
  • Misinformation through social media

COMMON FACILITATORS

  • Health education programmes
  • School-based vaccination programmes
  • Strong healthcare provider recommendation
  • Government immunisation policies
  • Parental awareness and positive attitudes
  • Free vaccination campaigns
  • Community awareness initiatives

METHODOLOGY

Study Design

 Systematic Review following PRISMA guidelines.

Inclusion Criteria

  • Studies published in English
  • Studies involving adolescents
  • Research on HPV vaccine uptake, barriers, or facilitators
  • Quantitative, qualitative, and mixed-method studies
  • Published within the last 10 years

Exclusion Criteria

  • Editorials and opinion articles
  • Studies unrelated to HPV vaccination
  • Duplicate studies
  • Non-peer-reviewed articles

Demographic Variables

Age

Educational status

Occupation

Marital status

Monthly income

Religion

Type of family

Source of health information

Previous history of cervical screening

 

Table: Characteristics of Selected Studies

 

S.N.

Author(s) & Year

Country

Study Design

Sample Size

Population

Identified Barriers

1

Smith et al. (221)

USA

Cross-sectional

450

Adolescents & Parents

Lack of awareness, fear of side effects

2

Lee et al. (2020)

South Korea

Descriptive Study

320

Adolescent girls

Cultural beliefs, misinformation

3

Kumar & Sharma (2022)

India

Mixed-method Study

280

Adolescents

Financial constraints, poor access

4

Ahmed et al. (2019)

Egypt

Qualitative Study

40

Parents of adolescents

Religious misconceptions

5

Johnson et al. (2023)

Canada

Cohort Study

510

School adolescents

Fear of adverse effects

6

Wang et al. (2021)

China

Cross-sectional

600

Adolescents

Lack of knowledge

7

Patel et al. (2020)

India

Quasi-experimental

150

Rural adolescents

Limited healthcare access

8

Garcia et al. (2022)

Spain

Survey Study

390

Parents & adolescents

Vaccine hesitancy

9

Brown et al. (2018)

UK

Cross-sectional

470

Adolescent girls

Peer misconceptions

10

Ali et al. (2024)

Pakistan

Descriptive Study

260

Adolescents

Low parental education

 

  • Knowledge
  • Attitude
  • Socioeconomic status
  • Cultural beliefs
  • Healthcare accessibility
  • Government policies

Dependent Variable

  • HPV immunisation uptake

DATABASES

 

  • PubMed
  • Scopus
  • Cochrane Library
  • Web of Science
  • Google Scholar

 

The following variables may be extracted from selected studies:

 

Variable

Description

Author & Year

Name of authors and publication year

Country

Study setting/location

Study Design

Type of research design

Sample Size

Total participants

Population

Adolescents/parents/healthcare workers

Barriers

Factors preventing HPV vaccination

Facilitators

Factors promoting HPV vaccination

Key Findings

Main study outcomes

 

Quality Appraisal Tools

 

Study Type

Appraisal Tool

Cross-sectional Studies

Joanna Briggs Institute (JBI) Checklist

Qualitative Studies

CASP Qualitative Checklist

Cohort Studies

Newcastle-Ottawa Scale

Mixed-method Studies

MMAT Tool

 

EXPECTED OUTCOME

The review may identify major barriers and facilitators influencing HPV vaccine uptake and provide evidence-based recommendations for improving adolescent immunisation coverage.

RECOMMENDATIONS

  • Strengthening school-based vaccination programmes
  • Increasing public awareness campaigns
  • Enhancing counselling by nurses and healthcare providers
  • Reducing misinformation regarding vaccine safety

Implementing free vaccination policies

REFERENCES

  1. Public Health Loke AY, Kwan ML, Wong YT, Wong AKY. The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review. SAGE Open Medicine. 2017;5:1–17.  
  2. Batista Ferrer H, Trotter C, Hickman M, Audrey S. Barriers and Facilitators to HPV Vaccination of Young Women in High-Income Countries: A Qualitative Systematic Review and Evidence Synthesis. BMC Public Health. 2014;14:700.  
  3. . Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol 2017; 40:80–85.
  4. Viens LJ, Henley SJ, Watson M, et l. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016; 65:661–666.
  5. de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141:664–670.
  6.  Centers for Disease Control and Prevention (CDC). Incidence, prevalence, and cost of sexually transmitted infections in the United States; 2013. Accessed January23, 2019 from: https://npin.cdc.gov/publication/incidence-prevalence-and-cost-sexually-transmitted-infections-united-states
  7.  Centers for Disease Control and Prevention (CDC). Prevalence of HPV in adults aged 18–69: United States, 2011–2014; 2017. Accessed March14, 2019 from: https://www.cdc.gov/std/hpv/stats.htm
  8. Han JJ, Beltran TH, Song JW, et al. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: national health and nutrition examination survey (NHANES) 2013–2014. JAMA Oncol. 2017;3(6):810–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moscicki AB, Palefsky JM. HPV in men: an update. J Low Genit Tract Disord. 2011;15(3):231–4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karakusevic A, Foss AM. Acceptability of Human Papillomavirus Vaccination in the United Kingdom: A Systematic Review of the Literature on Uptake of, and Barriers and Facilitators to HPV Vaccination. Therapeutic Advances in Vaccines and Immunotherapy. 2024.  
  11. Zheng L, Wu J. Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review. Sexually Transmitted Diseases. 2021;48(12):e255–e262.  
  12. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature. JAMA Pediatrics. 2014;168(1):76–82.  
  13. A Systematic Review of Human Papillomavirus Vaccination Among U.S. Adolescents. Journal of Pediatric Health Care. 2021.  
  14. Self-reported Barriers and Facilitators to Preventive Human Papillomavirus Vaccination Among Adolescent Girls and Young Women: A Systematic Review. Preventive Medicine. 2014;58:22–32.  
  15. Dibble KE, Maksut JL, Siembida EJ, Hutchison M, Bellizzi KM. A Systematic Literature Review of HPV Vaccination Barriers Among Adolescent and Young Adult Males. Journal of Adolescent and Young Adult Oncology. 2019.  
  16. Factors Affecting Human Papillomavirus Vaccination: A Review of Individual, Interpersonal, and Structural Factors Affecting Vaccine Uptake Among Adolescents. Vaccine. 2026.  
  17. Social Determinants of Health and Human Papillomavirus Vaccination Uptake: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. 2026.  

Reference

  1. Public Health Loke AY, Kwan ML, Wong YT, Wong AKY. The Uptake of Human Papillomavirus Vaccination and Its Associated Factors Among Adolescents: A Systematic Review. SAGE Open Medicine. 2017;5:1–17.  
  2. Batista Ferrer H, Trotter C, Hickman M, Audrey S. Barriers and Facilitators to HPV Vaccination of Young Women in High-Income Countries: A Qualitative Systematic Review and Evidence Synthesis. BMC Public Health. 2014;14:700.  
  3. . Brianti P, De Flammineis E, Mercuri SR. Review of HPV-related diseases and cancers. New Microbiol 2017; 40:80–85.
  4. Viens LJ, Henley SJ, Watson M, et l. Human papillomavirus–associated cancers—United States, 2008–2012. MMWR Morb Mortal Wkly Rep 2016; 65:661–666.
  5. de Martel C, Plummer M, Vignat J, et al. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer 2017; 141:664–670.
  6.  Centers for Disease Control and Prevention (CDC). Incidence, prevalence, and cost of sexually transmitted infections in the United States; 2013. Accessed January23, 2019 from: https://npin.cdc.gov/publication/incidence-prevalence-and-cost-sexually-transmitted-infections-united-states
  7.  Centers for Disease Control and Prevention (CDC). Prevalence of HPV in adults aged 18–69: United States, 2011–2014; 2017. Accessed March14, 2019 from: https://www.cdc.gov/std/hpv/stats.htm
  8. Han JJ, Beltran TH, Song JW, et al. Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: national health and nutrition examination survey (NHANES) 2013–2014. JAMA Oncol. 2017;3(6):810–6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Moscicki AB, Palefsky JM. HPV in men: an update. J Low Genit Tract Disord. 2011;15(3):231–4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karakusevic A, Foss AM. Acceptability of Human Papillomavirus Vaccination in the United Kingdom: A Systematic Review of the Literature on Uptake of, and Barriers and Facilitators to HPV Vaccination. Therapeutic Advances in Vaccines and Immunotherapy. 2024.  
  11. Zheng L, Wu J. Barriers to and Facilitators of Human Papillomavirus Vaccination Among People Aged 9 to 26 Years: A Systematic Review. Sexually Transmitted Diseases. 2021;48(12):e255–e262.  
  12. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to Human Papillomavirus Vaccination Among US Adolescents: A Systematic Review of the Literature. JAMA Pediatrics. 2014;168(1):76–82.  
  13. A Systematic Review of Human Papillomavirus Vaccination Among U.S. Adolescents. Journal of Pediatric Health Care. 2021.  
  14. Self-reported Barriers and Facilitators to Preventive Human Papillomavirus Vaccination Among Adolescent Girls and Young Women: A Systematic Review. Preventive Medicine. 2014;58:22–32.  
  15. Dibble KE, Maksut JL, Siembida EJ, Hutchison M, Bellizzi KM. A Systematic Literature Review of HPV Vaccination Barriers Among Adolescent and Young Adult Males. Journal of Adolescent and Young Adult Oncology. 2019.  
  16. Factors Affecting Human Papillomavirus Vaccination: A Review of Individual, Interpersonal, and Structural Factors Affecting Vaccine Uptake Among Adolescents. Vaccine. 2026.  
  17. Social Determinants of Health and Human Papillomavirus Vaccination Uptake: A Systematic Review. Journal of Obstetrics and Gynaecology Canada. 2026.  

Photo
Dr. Poonam Thakur
Corresponding author

Professor cum HOD (Obstetrics & Gynaecological Nursing) Postgraduate College of Nursing, CHRI, Gwalior (M.P)

Photo
Dr. C. R. Shamsheer Begum
Co-author

Principal (child health nursing),mims nursing institutes, VZM, Andhra Pradesh

Photo
Pragya Pathak
Co-author

Assistant professor (community health nursing),CON, GMC, Azamgarh

Photo
Ch. Lavanya
Co-author

Associate Professor 9community health nursing),GITAM Institute of Nursing, GITAM Deemed to be University, GIMSR, Hospital campus, Rushikonda, Visakhapatnam

Photo
Anjali
Co-author

Nursing Tutor (Community Health Nursing),CON, GMC, Azamgarh

Photo
Dr. Uma Rani
Co-author

Associate Professor (Medical and Surgical Nursing),Syadwad Institute of Higher Education and Research, Baghpat

Dr. C. R. Shamsheer Begum, Dr. Poonam Thakur, Pragya Pathak, Ch.Lavanya, Anjali, Dr. Uma Rani, Barriers And Facilitators to HPV Immunisation Uptake Among Adolescents: A Systematic Review, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 7, 5723-5729, https://doi.org/10.5281/zenodo.21697363

More related articles
Review Article of Eye Cosmetic Product...
Sapna, Simran Kaur, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Spectrophotometric Quantification Of Phosphate Lev...
V. G. Chougule, R. P. Umbare, S. V. Mali...
A Comprehensive Formulation Evaluation And Comp...
Satyadev Rentala, Sandeep vedanarayana M .S., K.Divya, Ramesh Mal...
Green Tea Niosomal Gel: An Approach For Protection Against Blue Light-Induced S...
Shubham Singh Panwar, Anju K. P., Saranya M., Sanmitha S., Deepika M. , Darakshan Bhat ...
Review Article on Impact of Alcohol Consumption on Male Fertility...
Harsh, Pardeep Kaur, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Related Articles
A Comprehensive Review on RP-HPLC Method Development and Validation for Simultan...
Vanita Sawant, Pratiksha Wagh, Nikita Mawal, Smita Aher...
Analytical Method Development and Validation for Quantitative Estimation of Diso...
Arpit Shinganjude, Nandini Tale, Shrutika Kawane, Shyamkumar Dabhade, Mahesh Jadhao, Sajeeyaparveen ...
COPD: A Review...
Ranvijay Kumar Singh , Lalit Kumar, Amar Pal Singh, Ajeet Pal Singh , Parul Verma...
Review Article on Pharmacovigilance...
Jaspreet Kaur, Gaurav Hastir, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
Review Article of Eye Cosmetic Product...
Sapna, Simran Kaur, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
More related articles
Review Article of Eye Cosmetic Product...
Sapna, Simran Kaur, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
A Comprehensive Formulation Evaluation And Complementary In-Silico Screening ...
Satyadev Rentala, Sandeep vedanarayana M .S., K.Divya, Ramesh Malothu...
Review Article of Eye Cosmetic Product...
Sapna, Simran Kaur, Amar Pal Singh, Ajeet Pal Singh, Rajesh Kumar...
A Comprehensive Formulation Evaluation And Complementary In-Silico Screening ...
Satyadev Rentala, Sandeep vedanarayana M .S., K.Divya, Ramesh Malothu...